Cognizin Ingredient Shown to Improve Focus, Concentration and Memory

26 Jan 2011 --- A six-week study conducted at McLean Hospital, a Harvard Medical School affiliate located in Belmont, Mass., was designed to measure and visualize the functional effects of Cognizin on various facets of brain function.

1/26/2011 --- Deborah Yurgelun-Todd, Ph.D., Director of the Cognitive Neuroimaging Laboratory at The Brain Institute at The University of Utah, presented new scientific data on Kyowa Hakko's branded brain health ingredient Cognizin at the SupplySide Science Tour held January 24, 2011, in Irvine, Calif. She highlighted results of a six-week study conducted at McLean Hospital, a Harvard Medical School affiliate located in Belmont, Mass., designed to measure and visualize the functional effects of Cognizin on various facets of brain function.

On the first day of testing, 16 healthy subjects aged 40 - 60 years underwent functional Magnetic Resonance Imaging (fMRI) while completing both the Stroop task, which is designed to measure attention and reaction time, and the Morris Water Maze task, which examines spatial memory. Subjects were then given a daily oral dose of either 500 or 2000 mg of Cognizin for six weeks before a second imaging protocol was conducted.

After completion of the second fMRI imaging test, increased activation was seen during completion of the Stroop interference task. This was accompanied by improved accuracy in generating correct responses. 

These results indicated that use of Cognizin resulted in a better, more accurate performance, accompanied by increased brain metabolism. 
Increased activation was seen during completion of the second Water Maze test as well. This was accompanied by increased time spent in the correct quadrant. These results indicated that use of Cognizin resulted in better spatial memory retrieval, in addition to increased brain metabolism. Results were nearly identical for individuals receiving 500 mg and 2000 mg of Cognizin, confirming that statistically significant improvements in attention, focus, memory and recall can be achieved at dosing levels of 500 mg.

"Neuroimaging data demonstrated increased regional brain activation, which was related to increased concentration, greater ability to focus and improved accuracy on cognitive tasks after subjects received Cognizin," noted Dr. Yurgelun-Todd. "Greater performance on a spatial memory task was also observed."

Cognizin Citicoline is a natural, water-soluble brain health ingredient, and is a well-established part of the cognitive health category. Vast research indicates this safe and effective branded compound helps protect neural tissue from free radical damage. It also supports brain performance by enhancing metabolism and healthy activity. Unlike other single-action ingredients for brain health, Cognizin is multi-functional. It has shown to benefit individuals affected by memory loss, mood/behavioral disorders, mild cognitive impairment and certain vision disorders.

Related Articles

Nutrition & Health News

Spotting the trends: Nexira explores natural ingredients with sought-after health benefits

16 Oct 2017 --- FODMAP friendly, vegan and flexitarian are no longer small niche markets; they are significant trends and their “claims” are being required more and more by end consumers in the US, the EU and the rest of the world. This is according to Julie Imperato, Nexira’s Marketing Manager.

Business News

Naturex and Milne partner on Concord grape extract research and commercialization

16 Oct 2017 --- Naturex’s Open Innovation Program Ingenium has led to the signing of a collaboration agreement with Milne Fruit Products, Inc. to jointly fund human clinical research utilizing Milne’s Concord grape aqueous extract. Concord grape (Vitis labrusca) is a North American fruit, whose unique grapes are rich in health-promoting polyphenols. The natural specialty ingredients supplier launched the open innovation program in March 2016 with the aim of advancing technological breakthroughs and accelerating the introduction of new products through external collaborations. 

Nutrition & Health News

Omega 6 rich diet linked to significantly reduced Type 2 diabetes risk

12 Oct 2017 --- The risk of developing Type 2 diabetes could be significantly reduced by eating a diet rich in omega 6 polyunsaturated fats, a new study suggests. These findings, published in The Lancet Diabetes & Endocrinology, shed new light on the potential health benefits of omega 6, which is found in bean and seed oils such as soybean and sunflower oils and in nuts. They also support clinical recommendations to increase dietary intake of omega 6 rich foods.

Nutrition & Health News

Black tea benefits weight loss as study suggests it is a prebiotic

04 Oct 2017 --- UCLA researchers have demonstrated for the first time that black tea may promote weight loss and other health benefits by altering bacteria in the gut. In a study of mice, the scientists showed that black tea alters energy metabolism in the liver by changing gut metabolites.

Nutrition & Health News

Anlit omega 3 supplement for children to debut under Meijer label

02 Oct 2017 --- Anlit Ltd is introducing its Omega Bites under the Meijer supermarket’s children’s label, which will see the product stocked in the US retailer's 230 supercenters and grocery stores. Omega Bites are a high-DHA+EPA omega 3 supplement in a fish-shaped orange-chocolate flavored chewable, developed to help overcome children's natural reluctance to taking nutritional supplements.

More Articles
URL : http://www.nutritioninsight.com:80/news/Cognizin-Ingredient-Shown-to-Improve-Focus-Concentration-and-Memory.html